Global Diphtheria Toxoid 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR022504709

Publication Date:

February 17, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Diphtheria Toxoid market size was valued at US$ 232 million in 2024 and is forecast to a readjusted size of USD 339 million by 2031 with a CAGR of 5.7% during review period.
Diphtheria toxoid is a biological product that is detoxified by diphtheria toxin plus formaldehyde at a certain temperature and becomes non-toxic while still maintaining immunogenicity. It is the most effective preparation to prevent diphtheria.

This report is a detailed and comprehensive analysis for global Diphtheria Toxoid market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Diphtheria Toxoid market size and forecasts, in consumption value ($ Million), 2020-2031
Global Diphtheria Toxoid market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Diphtheria Toxoid market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Diphtheria Toxoid market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diphtheria Toxoid
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diphtheria Toxoid market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocompare, GSK, Zoetis, Sanofi, Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Diphtheria Toxoid market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Reducing Toxin
Denatured Toxin
麻豆原创 segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
麻豆原创 segment by players, this report covers
Biocompare
GSK
Zoetis
Sanofi
Merck
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diphtheria Toxoid product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diphtheria Toxoid, with revenue, gross margin, and global market share of Diphtheria Toxoid from 2020 to 2025.
Chapter 3, the Diphtheria Toxoid competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Diphtheria Toxoid market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diphtheria Toxoid.
Chapter 13, to describe Diphtheria Toxoid research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Diphtheria Toxoid by Type
1.3.1 Overview: Global Diphtheria Toxoid 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Diphtheria Toxoid Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Reducing Toxin
1.3.4 Denatured Toxin
1.4 Global Diphtheria Toxoid 麻豆原创 by Application
1.4.1 Overview: Global Diphtheria Toxoid 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Centers
1.5 Global Diphtheria Toxoid 麻豆原创 Size & Forecast
1.6 Global Diphtheria Toxoid 麻豆原创 Size and Forecast by Region
1.6.1 Global Diphtheria Toxoid 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Diphtheria Toxoid 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Diphtheria Toxoid 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Diphtheria Toxoid 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Diphtheria Toxoid 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Diphtheria Toxoid 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Diphtheria Toxoid 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Biocompare
2.1.1 Biocompare Details
2.1.2 Biocompare Major Business
2.1.3 Biocompare Diphtheria Toxoid Product and Solutions
2.1.4 Biocompare Diphtheria Toxoid Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Biocompare Recent Developments and Future Plans
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Diphtheria Toxoid Product and Solutions
2.2.4 GSK Diphtheria Toxoid Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 GSK Recent Developments and Future Plans
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Diphtheria Toxoid Product and Solutions
2.3.4 Zoetis Diphtheria Toxoid Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Zoetis Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Diphtheria Toxoid Product and Solutions
2.4.4 Sanofi Diphtheria Toxoid Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Diphtheria Toxoid Product and Solutions
2.5.4 Merck Diphtheria Toxoid Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Merck Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Diphtheria Toxoid Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Diphtheria Toxoid by Company Revenue
3.2.2 Top 3 Diphtheria Toxoid Players 麻豆原创 Share in 2024
3.2.3 Top 6 Diphtheria Toxoid Players 麻豆原创 Share in 2024
3.3 Diphtheria Toxoid 麻豆原创: Overall Company Footprint Analysis
3.3.1 Diphtheria Toxoid 麻豆原创: Region Footprint
3.3.2 Diphtheria Toxoid 麻豆原创: Company Product Type Footprint
3.3.3 Diphtheria Toxoid 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Diphtheria Toxoid Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Diphtheria Toxoid 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Diphtheria Toxoid Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Diphtheria Toxoid 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Diphtheria Toxoid Consumption Value by Type (2020-2031)
6.2 North America Diphtheria Toxoid 麻豆原创 Size by Application (2020-2031)
6.3 North America Diphtheria Toxoid 麻豆原创 Size by Country
6.3.1 North America Diphtheria Toxoid Consumption Value by Country (2020-2031)
6.3.2 United States Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Diphtheria Toxoid Consumption Value by Type (2020-2031)
7.2 Europe Diphtheria Toxoid Consumption Value by Application (2020-2031)
7.3 Europe Diphtheria Toxoid 麻豆原创 Size by Country
7.3.1 Europe Diphtheria Toxoid Consumption Value by Country (2020-2031)
7.3.2 Germany Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Diphtheria Toxoid Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Diphtheria Toxoid Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Diphtheria Toxoid 麻豆原创 Size by Region
8.3.1 Asia-Pacific Diphtheria Toxoid Consumption Value by Region (2020-2031)
8.3.2 China Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Diphtheria Toxoid Consumption Value by Type (2020-2031)
9.2 South America Diphtheria Toxoid Consumption Value by Application (2020-2031)
9.3 South America Diphtheria Toxoid 麻豆原创 Size by Country
9.3.1 South America Diphtheria Toxoid Consumption Value by Country (2020-2031)
9.3.2 Brazil Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Diphtheria Toxoid Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Diphtheria Toxoid Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Diphtheria Toxoid 麻豆原创 Size by Country
10.3.1 Middle East & Africa Diphtheria Toxoid Consumption Value by Country (2020-2031)
10.3.2 Turkey Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Diphtheria Toxoid 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Diphtheria Toxoid 麻豆原创 Drivers
11.2 Diphtheria Toxoid 麻豆原创 Restraints
11.3 Diphtheria Toxoid Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Diphtheria Toxoid Industry Chain
12.2 Diphtheria Toxoid Upstream Analysis
12.3 Diphtheria Toxoid Midstream Analysis
12.4 Diphtheria Toxoid Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Biocompare
GSK
Zoetis
Sanofi
Merck

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.